Skip to main content

Figure 5  .

Figure 5  

Representative bitmap images illustrating distribution of Fos-like (Fos-LI) immunoreactivity in all treatment groups: (A) sham distended; (B) control colorectal distention (CRD); (C) CRD/alosetron, 30 µg/kg; (D) CRD/alosetron 100 µg/kg. Horizontal scale bar, 150 µm; arrows indicate examples of Fos-LI nuclei.